메뉴 건너뛰기




Volumn 10, Issue 8, 2014, Pages 431-432

The search goes on: SuPAR is not the elusive FSGS factor

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA3 INTEGRIN; LIPOPOLYSACCHARIDE; RECOMBINANT PROTEIN; SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

EID: 84905089929     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2014.113     Document Type: Short Survey
Times cited : (14)

References (10)
  • 1
    • 80053485070 scopus 로고    scopus 로고
    • Immunosuppressive treatment of focal segmental glomerulosclerosis: Lessons from a randomized controlled trial
    • Deegens, J. K. & Wetzels, J. F. Immunosuppressive treatment of focal segmental glomerulosclerosis: Lessons from a randomized controlled trial. Kidney Int. 80, 798-801 (2011
    • (2011) Kidney Int , vol.80 , pp. 798-801
    • Deegens, J.K.1    Wetzels, J.F.2
  • 2
    • 84878656609 scopus 로고    scopus 로고
    • Serum suPAR in patients with FSGS: Trash or treasure?
    • Maas, R. J., Deegens, J. K. & Wetzels, J. F. Serum suPAR in patients with FSGS: Trash or treasure?. Paediatr. Nephrol. 28, 1041-1048 (2013
    • (2013) Paediatr. Nephrol. , vol.28 , pp. 1041-1048
    • Maas, R.J.1    Deegens, J.K.2    Wetzels, J.F.3
  • 3
    • 84908369031 scopus 로고    scopus 로고
    • Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice
    • Cathelin, D. et al. Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2013040425
    • J. Am. Soc. Nephrol
    • Cathelin, D.1
  • 4
    • 0035144268 scopus 로고    scopus 로고
    • Successful transplant of a kidney with focal segmental glomerulosclerosis
    • Rea, R., Smith, C., Sandhu, K., Kwan, J. & Tomson, C. Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 16, 416-417 (2001
    • (2001) Nephrol. Dial. Transplant , vol.16 , pp. 416-417
    • Rea, R.1    Smith, C.2    Sandhu, K.3    Kwan, J.4    Tomson, C.5
  • 5
    • 78149297155 scopus 로고    scopus 로고
    • Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis
    • McCarthy, E. T., Sharma, M. & Savin, V. J. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 5, 2115-2121 (2010
    • (2010) Clin. J. Am. Soc. Nephrol , vol.5 , pp. 2115-2121
    • McCarthy, E.T.1    Sharma, M.2    Savin, V.J.3
  • 6
    • 79961132981 scopus 로고    scopus 로고
    • Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
    • Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952-960 (2011
    • (2011) Nat. Med , vol.17 , pp. 952-960
    • Wei, C.1
  • 7
    • 38049032013 scopus 로고    scopus 로고
    • Modification of kidney barrier function by the urokinase receptor
    • Wei, C. et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14, 55-63 (2008
    • (2008) Nat. Med , vol.14 , pp. 55-63
    • Wei, C.1
  • 8
    • 84895119023 scopus 로고    scopus 로고
    • Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?
    • Schlondorff, D. Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?. Kidney Int. 85, 499-501 (2014
    • (2014) Kidney Int , vol.85 , pp. 499-501
    • Schlondorff, D.1
  • 9
    • 84895155571 scopus 로고    scopus 로고
    • The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
    • Meijers, B. et al. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int. 85, 636-640 (2014
    • (2014) Kidney Int , vol.85 , pp. 636-640
    • Meijers, B.1
  • 10
    • 84881244297 scopus 로고    scopus 로고
    • Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: A single-centre report
    • Bock, M. E., Price, H. E., Gallon, L. & Langman, C. B. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: A single-centre report. Clin. J. Am. Soc. Nephrol. 8, 1304-1311 (2013
    • (2013) Clin. J. Am. Soc. Nephrol , vol.8 , pp. 1304-1311
    • Bock, M.E.1    Price, H.E.2    Gallon, L.3    Langman, C.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.